<code id='0D743A074D'></code><style id='0D743A074D'></style>
    • <acronym id='0D743A074D'></acronym>
      <center id='0D743A074D'><center id='0D743A074D'><tfoot id='0D743A074D'></tfoot></center><abbr id='0D743A074D'><dir id='0D743A074D'><tfoot id='0D743A074D'></tfoot><noframes id='0D743A074D'>

    • <optgroup id='0D743A074D'><strike id='0D743A074D'><sup id='0D743A074D'></sup></strike><code id='0D743A074D'></code></optgroup>
        1. <b id='0D743A074D'><label id='0D743A074D'><select id='0D743A074D'><dt id='0D743A074D'><span id='0D743A074D'></span></dt></select></label></b><u id='0D743A074D'></u>
          <i id='0D743A074D'><strike id='0D743A074D'><tt id='0D743A074D'><pre id='0D743A074D'></pre></tt></strike></i>

          Home / knowledge / leisure time

          leisure time


          leisure time

          author:fashion    Page View:48
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In